Effects of Integrin‐Linked Kinase Silencing Combined With Trichostatin A on Cancer Stem Cells

Trichostatin A Integrin-linked kinase
DOI: 10.1111/odi.15377 Publication Date: 2025-05-14T05:14:36Z
ABSTRACT
ABSTRACT Objectives Oral squamous cell carcinoma (OSCC) is characterized by high invasiveness and metastasis, with cancer stem cells (CSCs) playing a central role in tumor progression. This study investigates the effects of integrin‐linked kinase (ILK) silencing trichostatin A (TSA) treatment on CSCs, assessing their potential to diminish CSC properties inhibit OSCC Methods Materials CSCs were enriched isolated from primary samples Tca8113 line MOC1 using side population (SP) analysis, characteristics therapeutic impact treatments assessed through assays such as MTT, wound healing, invasion, cycle, apoptosis. Results Higher SP content correlated significantly poor pathological classification, recurrence. Treated showed reduced proliferation, migration, along increased In vivo experiments demonstrated that combined substantially growth. Conclusion The confirms efficacy targeting ILK TSA OSCC, suggesting promising strategy for CSC‐directed therapies merit further investigation.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (28)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....